Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma

Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinomaGlypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, Published online: 12 January 2018; doi:10.1038/modpathol.2017.190Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma

Source: Modern Pathology - January 12, 2018 Category: Pathology Authors: Vishwa Jeet Amatya Kei Kushitani Yuichiro Kai Rui Suzuki Yoshihiro Miyata Morihito Okada Yukio Takeshima Source Type: research